Graves Ophthalmopathy
📧 Sign up to get email alerts when something new happens for Graves Ophthalmopathy.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2026-03-09Clinical Trial Update: A Study to Evaluate the Efficacy and Safety of LASN01 in Patients With Thyroid Eye Disease [Phase 2]
A Phase 2 study evaluating the efficacy and safety of LASN01 in Thyroid Eye Disease (Graves' ophthalmopathy) has completed and results are p…
-
CLINICAL_TRIALS trial_result · 2025-12-31Clinical Trial Update: Anti-VEGF Therapy for Acute Thyroid Eye Disease [Phase 2]
A Phase 2 trial evaluating anti-VEGF therapy for acute thyroid eye disease has completed, potentially informing efficacy and safety signals.
-
CLINICAL_TRIALS trial_result · 2025-03-19Clinical Trial Update: Glucocorticoids and Bone in Graves' Ophthalmopathy
Clinical trial update reporting results for a completed study on the impact of glucocorticoids on bone health in Graves' ophthalmopathy; res…
-
CLINICAL_TRIALS trial_result · 2025-02-25Clinical Trial Update: Extension Study of Two Doses of Linsitinib in Subjects With Active, Moderate to Severe Thyroid Eye Disease (TED) [Phase 2, Phase 3]
An extension study of two doses of Linsitinib for Thyroid Eye Disease is in Phase 2/3 and currently recruiting, sponsored by Sling Therapeut…
-
CLINICAL_TRIALS trial_result · 2024-12-27Clinical Trial Update: Efficacy and Safety of SHR-1314 by Subcutaneous Injection in Active Moderate to Severe Graves' Orbitopathy Patients [Phase 2]
A Phase 2 trial evaluating SHR-1314 for active moderate-to-severe Graves' ophthalmopathy has been terminated, with the update covering its e…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2023-03-15Clinical Trial Update: Sirolimus for Graves' Orbitopathy (GO) [Phase 2]
Phase 2 clinical trial evaluating sirolimus for Graves' Ophthalmopathy is in a phase 2 study with unknown status.
-
CLINICAL_TRIALS trial_result · 2023-03-15Clinical Trial Update: A Trial to Evaluate the Efficacy of Orbital Radiotherapy in Graves' Orbitopathy [Phase 4]
Phase 4 clinical trial evaluating the efficacy of orbital radiotherapy for Graves' ophthalmopathy (thyroid-associated ophthalmopathy).
-
CLINICAL_TRIALS trial_result · 2022-09-22Clinical Trial Update: ASCEND GO-2: Study of RVT-1401 for the Treatment of Participants With Active, Moderate to Severe Graves' Ophthalmopathy ( GO ) [Phase 2]
Phase 2 study of RVT-1401 for Graves' Ophthalmopathy was terminated; results posted in 2022.
-
CLINICAL_TRIALS trial_result · 2022-08-04Clinical Trial Update: Tocilizumab in Active Moderate-severe Graves' Orbitopathy [Phase 2]
Phase 2 clinical trial update evaluating tocilizumab for active moderate-to-severe Graves' ophthalmopathy.
-
CLINICAL_TRIALS trial_result · 2022-01-24Clinical Trial Update: Study of RVT-1401 for the Treatment of Patients With Moderate to Severe Active Graves' Ophthalmopathy (GO) [Phase 2]
Phase 2 trial of RVT-1401 for Graves' Ophthalmopathy completed; results posted in 2022.
-
CLINICAL_TRIALS trial_result · 2021-11-17Clinical Trial Update: Doxycycline Treatment in Mild Thyroid-Associated Ophthalmopathy [Phase 2]
Phase 2 clinical trial update evaluating doxycycline for mild thyroid-associated ophthalmopathy (Graves-related eye disease).
-
CLINICAL_TRIALS trial_result · 2018-09-13Clinical Trial Update: Liver Function After Intravenous Methylprednisolone Administration [Phase 4]
A Phase 4 clinical trial update evaluating liver function following intravenous methylprednisolone administration in Graves disease and Grav…
-
CLINICAL_TRIALS trial_result · 2018-07-30Clinical Trial Update: Anti-insulin-like Growth Factor-1 Receptor (IGF-1R) Antibodies in Graves' Disease and Graves' Orbitopathy
Clinical trial update on anti-IGF-1R antibodies for Graves' disease and Graves' ophthalmopathy; the study status is completed.
-
CLINICAL_TRIALS trial_result · 2018-07-18Clinical Trial Update: Impact of Intravenous Methylprednisolone Treatment on Blood Pressure
The clinical trial evaluating intravenous methylprednisolone's impact on blood pressure in Graves disease and Graves ophthalmopathy has comp…
-
CLINICAL_TRIALS trial_result · 2018-05-24Clinical Trial Update: Coagulation After Intravenous Methylprednisolone Administration
The document summarizes the completed clinical trial evaluating coagulation effects after intravenous methylprednisolone administration in p…
-
CLINICAL_TRIALS trial_result · 2018-02-19Clinical Trial Update: Treatment of Soft Tissue Expansion in Inactive Thyroid Eye Disease Patients Using Drops of Prostaglandin Analogues [Phase 3]
Phase 3 trial assessing prostaglandin analogue drops for treating soft tissue expansion in inactive thyroid eye disease (thyroid-associated …
-
CLINICAL_TRIALS trial_result · 2017-08-30Clinical Trial Update: Teprotumumab (RV 001) Treatment in Patients With Active Thyroid Eye Disease [Phase 2]
Phase 2 trial of teprotumumab in active thyroid eye disease completed; results were posted in 2017.
-
CLINICAL_TRIALS trial_result · 2017-08-03Clinical Trial Update: A Safety and Tolerability Study of Otelixizumab in Thyroid Eye Disease [Phase 2]
Phase 2 safety and tolerability study of Otelixizumab in Graves Ophthalmopathy was terminated; results posted in 2017.
-
CLINICAL_TRIALS trial_result · 2017-05-30Clinical Trial Update: Randomized Study of Sequential Orbital Radiotherapy for Graves' Ophthalmopathy [NA]
The randomized study evaluating sequential orbital radiotherapy for Graves' ophthalmopathy has completed.
-
CLINICAL_TRIALS trial_result · 2017-04-06Clinical Trial Update: Disappearance of Graves' Orbitopathy
A completed clinical trial by the University of Pisa in Thyroid Eye Disease reports disappearance of Graves' ophthalmopathy.
-
CLINICAL_TRIALS trial_result · 2017-02-28Clinical Trial Update: Total Thyroidectomy Versus Thionamides in Patients With Moderate-to-Severe Graves' Ophthalmopathy [Phase 3]
Phase 3 clinical trial update comparing total thyroidectomy to thionamide therapy in patients with moderate-to-severe Graves' ophthalmopathy…
-
CLINICAL_TRIALS trial_result · 2016-05-10Clinical Trial Update: Optic Disc, Macula, and Retinal Nerve Fiber Layer Measurements Obtained by OCT in Thyroid Associated Ophthalmopathy [NA]
A completed clinical trial evaluated optic disc, macula, and retinal nerve fiber layer measurements using OCT in Graves' ophthalmopathy.
-
CLINICAL_TRIALS trial_result · 2016-05-06Clinical Trial Update: Prostaglandin F2-alpha Eye Drops in Thyroid Eye Disease (Bima Study) [Phase 4]
Phase 4 clinical trial evaluating Prostaglandin F2-alpha Eye Drops for Graves' Ophthalmopathy has completed (Bima Study).
-
CLINICAL_TRIALS trial_result · 2016-02-24Clinical Trial Update: Adjuvant Treatment of Graves´ Ophthalmopathy With NSAID (aGO Study) [Phase 4]
This document reports the completion of a Phase 4 clinical trial evaluating adjuvant NSAID therapy for Graves' ophthalmopathy in Graves' dis…
-
CLINICAL_TRIALS trial_result · 2016-01-20Clinical Trial Update: Tocilizumab Treatment in Graves´ Ophthalmopathy (Graves´ Orbitopathy or Thyroid Eye Disease) [Phase 3]
Phase 3 trial assessing tocilizumab for Graves' ophthalmopathy (thyroid eye disease) has completed.